The Latest Breaking News from Cancer

Merck Co. Inc. (NYSE:MRK) announced data from the Phase 3 KEYNOTE-B96 trial (ENGOT-ov65) of Keytruda (pembrolizumab) in combination with chemotherapy (paclitaxel) with or without Roche Holdings AG’s (OTC:RHHBY) Avastin (bevacizumab).

Thousands of claimants in the U.K. are suing Johnson Johnson (NYSE:JNJ), accusing the healthcare giant of knowingly selling asbestos-contaminated talcum powder that allegedly caused cancer in consumers. The case, involving roughly 3,000 individuals, is one of the largest product liability claims of its kind to reach the High Court in…

Relationship expert and woman&home columnist Anna Richardson helps a reader with a friendship problem

The pharmaceutical company has been accused of ‘concealing’ the risk to the public for decades

A mother has pleaded guilty to deception charges over a scam in which she solicited donations after faking her six-year-old son's cancer diagnosis.

Prolonged exposure to UVA accelerates skin ageing and increases the risk of cancer, but this wearable device could signal when it hits dangerous levels

After hitting $100, Tempus AI has retreated, but shares have still provided huge returns. Multiple factors suggest that the stock could see a larger correction.

Have you ever brushed off a symptom that turned out to be cancerous?

'Dawson's Creek' star James Van Der Beek is battling stage 3 colorectal cancer; he missed a New York reunion but sent a video message, as co-stars and fans rally and doctors urge screening.